Authors


Dr Brandon Huynh, Prof. Peter Shah, Dr Freda Sii, Dr Damien Hunter, Dr Nicole Carnt and Dr Andrew White

Latest:

Is low vitamin D a risk factor for primary open angle glaucoma?

Evidence for a connection between low vitamin D levels and glaucoma is increasing but the link remains speculative and no causal connection has been demonstrated.


Dr Vidushi Golash

Latest:

Not just for eating: Grapes and potatoes help surgery trainees hone skills

The pandemic has impacted ophthalmic surgical training. Exercises have been developed to provide key skills that can be practised simply at home and require no special equipment.


Dr Jose Carlos Pastor

Latest:

The cost of the H-index

The price tag of publishing presents a tricky research barrier


Dr David P Piñero, Dr María B Coco-Martin, Mr Luis Leal-Vega, Mr Carlos J Hernández-Rodríguez and Dr Ainhoa Molina-Martín

Latest:

Use of virtual reality training in amblyopia

Virtual reality dichoptic and perceptual learning training seem to be a useful therapeutic option for achieving a successful visual rehabilitation in amblyopic patients.


Mr Alastair Stuart

Latest:

A new lens option for enhanced monovision performance

In “modified monovision”, which can be achieved with a new IOL, one eye predominantly manages distance vision and the other near vision—as with standard monovision—but the extended depth of field provides a degree of intermediate vision that is independent of spectacles.


Dr Andreas F. Borkenstein

Latest:

YAG-shots in IOLs: Safe or dangerous?

Poorly focused YAG shots lead irrevocably to a permanent defect in the IOL material and thus to possible effects on the quality of vision with straylight or glare. In a recent study, the differing amounts of damage that Nd:YAG causes in a range of hydrophilic and hydrophobic acrylic lens materials was assessed.


Mr Md Oliullah Abdal

Latest:

Digital visual training helps treat disorders associated with close work

Computer software platform provides home vision exercises to overcome asthenopia.


Cheryl Guttman Krader; Reviewed by Dr Christine Kay

Latest:

Gene therapy heralds new era for inherited retinal diseases

Gene therapies are being investigated for multiple inherited retinal diseases and the progress in this field has implications for patient care.


Dr Steven I. Rosenfeld

Latest:

Optimising the ocular surface to achieve good vision after surgery

Patients need to pay attention to their eye health over the long term.


Dr Giacomo Savini

Latest:

Better IOL calculation in post-LASIK eyes

To heighten precision, use total keratometry, not imaginary numbers


Lynda Charters; Reviewed by Dr William J. Johnson

Latest:

Corneal crosslinking outcomes appear to justify its use in paediatrics

Studies show that corneal crosslinking could be a beneficial treatment in paediatric patients with keratoconus.




Prof. Gábor Jandó

Latest:

Amblyopia screening with the dynamic random dot stereotest

A new amblyopia screening system that can be used on Android devices has performed better than some of the ‘gold standard’ stereotests in recent Hungarian studies.


Dr Eva-Maria Borkenstein

Latest:

YAG-shots in IOLs: Safe or dangerous?

Poorly focused YAG shots lead irrevocably to a permanent defect in the IOL material and thus to possible effects on the quality of vision with straylight or glare. In a recent study, the differing amounts of damage that Nd:YAG causes in a range of hydrophilic and hydrophobic acrylic lens materials was assessed.


Arshad M. Khanani MD, MA, FASRS

Latest:

Learnings from Real World Evidence of Faricimab in nAMD and DME: Part 2

Arshad M. Khanani, MD, MA, FASRS, highlights the fluid resolution with faricimab and the need for loading doses, especially in high-needs switch patients with nAMD or DME.


Dr Dain B. Brooks

Latest:

Surgical options for normalising neuroadaptation

It is important to select good candidates for presbyopia-correcting IOL implantation and frankly discuss postoperative adjustment issues for a successful outcome.


Dr Thomas V. Johnson III

Latest:

Restoring vision through retinal ganglion cell repopulation

RGC replacement represents a more formidable challenge.


Thales A.C. de Guimaraes, MD

Latest:

Dry AMD: A review of ongoing, completed and future treatments

The most promising recent interventional trials for investigational therapies in dry age-related macular degeneration are highlighted by the authors.


Emily Kaiser Maharjan

Latest:

United States FDA approves two aflibercept 2 mg biosimilars

The agency issued approval for Yesafili, from Biocon Biologics, and Opuviz, from Samsung Bioepis and Biogen


Dr Marcus Blum

Latest:

Lenticule extraction in hyperopia – an update

A multicentre study demonstrates comparable results to FS-LASIK


Lynda Charters; Reviewed by Dr Michael X. Repka

Latest:

Exploring possibilities of myopia prevention and control in the US

Investigators have indicated that combination therapies of outdoor activity, bifocals and low-dose atropine are being studied.


Dr Simerdip Kaur

Latest:

Not just for eating: Grapes and potatoes help surgery trainees hone skills

The pandemic has impacted ophthalmic surgical training. Exercises have been developed to provide key skills that can be practised simply at home and require no special equipment.


By Lynda Charters; Reviewed by Clara Chan, MD

Latest:

Surgical taming of neurotrophic keratopathy: From amniotic membrane grafting to neurotisation

Clara Chan, MD, shares surgical pearls for neurotrophic keratopathy and explores new pathways through neurotisation


Shu-I Yeh, MD, PhD

Latest:

New strategies for severe ocular surface and corneal disease

Regenerative technologies are providing an influx of options.


Dr Imran Masood

Latest:

Averting zonular crises in different types of cataract patients

Zonular crises occur due to many different aetiologies, but ophthalmologists now have multiple tools available to solve complex problems and achieve excellent results in complex cases.


Rod McNeil

Latest:

Investigative antibody shows sustained efficacy in retinal disease studies

Results from Phase 3 trials of bispecific antibody faricimab demonstrate that it is more durable than currently available agents, and it has a good safety profile.


Dr Basak Bostanci

Latest:

Considerations when using IOLs in patients with complex corneas

Non-diffractive lenses offer alternative in challenging post-corneal refractive surgery cases.


Cynthia A. Challener

Latest:

Addressing the challenge of patient compliance with topical ophthalmic drugs

Patient centricity an important driver in topical development.


Dr Kolawole Ogundimu

Latest:

Pilot project aims to overcome inequalities in glaucoma diagnoses

Many low- and middle-income countries lack resources for managing eye health. A pilot project aims to reduce the number of people going blind from untreated glaucoma by raising awareness and increasing engagement with screening and follow-up.

© 2024 MJH Life Sciences

All rights reserved.